SEC Form 4 · accession 0001406618-18-000001
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey G Park
Officer — Interim CEO · Director
Period of report
Jan 4, 2018
Accepted (ET)
Jan 8, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2018 | A | 48,146 | $0.00 | A | 55,786 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 4, 2018, the reporting person received a grant of restricted stock with a total value of $1,000,000, with such award to vest pro rata in four equal installments on March 31, June 30, September 30 and December 31, 2018, with the number of common shares to be received as of each vesting date based on the Company's closing common stock price on the NYSE as of such vesting date, or the Company's closing common stock price on the NYSE as of the business day immediately preceding such vesting date, in the event the vesting date is not a business day. The share amounts reported in columns 4 and 5 represent the estimated number of shares to be issued based on the Company's closing common stock price on the NYSE as of the grant date.